Skip to main content
  • Dapagliflozin Safe in Older Patients With AS, HF Undergoing TAVI

    Dapagliflozin significantly lowers the rate of death from any cause or worsening heart failure (HF) compared with standard care alone in elderly patients with aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI), data from a newly published trial show. 

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details